• Profile
Close

Assessment of serum interleukin‐19 in acne vulgaris patients of different clinical severities

Journal of Cosmetic Dermatology Feb 18, 2021

Saleh HM, et al. - In this observational analytical cross-sectional pilot study involving 120 individuals, aged 18 to 30 years, researchers sought to measure serum levels of interleukin 19 (IL‐19) in acne vulgaris patients with different severities, and compare it with healthy controls, to assess its role in the pathogenesis of acne vulgaris and correlate it with acne severity. Participants were divided into four groups, 30 in each; mild, moderate, and severe AV patients groups according to acne severity as well as apparently healthy controls group of matched age and sex with no known history of acne or active acne. According to findings, IL‐19 is linked to the etiopathological inflammatory process of acne vulgaris and correlates with the severity of acne. As a prognostic inflammatory marker, it may be proposed for acne vulgaris.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay